Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Antimicrobial Agents and Chemotherapy|March 21, 2007
Longitudinally tracking fluoroquinolone resistance and its determinants in penicillin-susceptible and -nonsusceptible Streptococcus pneumoniae isolates in Hong Kong, 2000 to 2005Margaret Ip, Shirley S L Chau, Fang Chi, et al.
Journal of Clinical Microbiology|April 6, 2007
Serotype distribution and antimicrobial susceptibilities of nasopharyngeal isolates of Streptococcus pneumoniae from children hospitalized for acute respiratory illnesses in Hong KongMargaret Ip, E Anthony S Nelson, Edmund S C Cheuk, et al.
Behavior Therapy|August 19, 2007
Initial psychometric properties of the experiences questionnaire: validation of a self-report measure of decenteringDavid M Fresco, Michael T Moore, Manfred H M van Dulmen, et al.
The Clinical Journal of Pain|July 15, 2011
Comparing the effectiveness of mindfulness-based stress reduction and multidisciplinary intervention programs for chronic pain: a randomized comparative trialSamuel Yeung-Shan Wong, Frank Wan-Kin Chan, Rebecca Lai-Ping Wong, et al.
Molecular Cancer Therapeutics|February 6, 2016
Effective Concentration of a Multikinase Inhibitor within Bone Marrow Correlates with In Vitro Cell Killing in Therapy-Resistant Chronic Myeloid LeukemiaChaofeng Mu, Xiaoyan Wu, Helen Ma, et al.
Genes, Chromosomes & Cancer|July 3, 2020
Generation of pralatrexate resistant T-cell lymphoma lines reveals two patterns of acquired drug resistance that is overcome with epigenetic modifiersLuigi Scotto, Cristina Kinahan, Beatrice Casadei, et al.
Cancer|December 8, 2022
Triple combination targeting methyltransferase, BCL-2, and PD-1 facilitates antileukemia responses in acute myeloid leukemiaZhihong Zeng, Abhishek Maiti, Shelley Herbrich, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 7, 2019
Oral MEK 1/2 Inhibitor Trametinib in Combination With AKT Inhibitor GSK2141795 in Patients With Acute Myeloid Leukemia With RAS Mutations: A Phase II StudyBrittany Knick Ragon, Olatoyosi Odenike, Maria R Baer, et al.
Journal of Clinical Medicine|July 15, 2026
Beyond the Battlefield: Lymphoma Outcomes in Post-9/11 Service Members and VeteransSteven J Gibson, Matthew J Rendo, Helen Ma, et al.
Cell Reports|January 12, 2017
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in LeukemiaJon Kerry, Laura Godfrey, Emmanouela Repapi, et al.
Pageof 6